24/7 Customer Support
doublle@doubllebio.com
DOUBLLE BIODOUBLLE BIO
  • Home
  • About
    • Corporate Honors
    • Team
  • Product
  • Service
    • Clinical Recruitment
  • News
  • Contact
  • CN
  • Home
  • About
    • Corporate Honors
    • Team
  • Product
  • Service
    • Clinical Recruitment
  • News
  • Contact
  • CN
+86 020 32053707
+86 020 32053707
Home Doublle › Blog – [Duplicated]
2026年3月22日

Enrollment Completed for Doublle Bio hUC-MSCs Phase I Low-Dose Group

Company News No Comments 290 Views
The enrollment of the low-dose group in the Phase I clinical trial of Dabao Biological Human Umbilical Cord Mesenchymal Stem Cells has been completed
2026年3月20日

[Patient Recruitment] Clinical Recruitment for Stem Cell Treatment of Type 2 Diabetes

Clinical progress No Comments 238 Views
Phase I clinical study on the safety, tolerability, and preliminary efficacy of E10I stem cell therapy for type 2 diabetes
2026年3月10日

GuangZhou Doublle Biotech successfully passed the CNAS regular supervision and expans…

Company News No Comments 210 Views
The Biological Testing Center of Guangzhou Doublle Biological Products Co., Ltd. has successfully passed the regular supervision review and testing capability expansion review conducted by the China National Accreditation Service for Conformity Assessment (CNAS)

About Us

The company was founded by Professor Huang Wenlin in 2001, and has been dedicated to the development and transformation of gene engineering technology applications, such as tumor-targeted drug gene therapy and cell therapy.

Our Contact Details

8th Floor, Building B1, Guangzhou Technology Business Accelerator

+86 020 32053707

doublle@doubllebio.com

QR code to contact

Copyright © GuangZhou Doublle Bio | All rights reserved.